204 related articles for article (PubMed ID: 23981200)
81. Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection.
Zhou ZJ; Xin HY; Li J; Hu ZQ; Luo CB; Zhou SL
Cancer Immunol Immunother; 2019 Aug; 68(8):1223-1233. PubMed ID: 31201473
[TBL] [Abstract][Full Text] [Related]
82. Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY
Mol Biol Rep; 2012 May; 39(5):6001-6. PubMed ID: 22205539
[TBL] [Abstract][Full Text] [Related]
83. α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC.
Xu B; Cai Z; Zeng Y; Chen L; Du X; Huang A; Liu X; Liu J
J Clin Pathol; 2014 Nov; 67(11):974-9. PubMed ID: 25092674
[TBL] [Abstract][Full Text] [Related]
84. High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection.
Jia JB; Wang WQ; Sun HC; Zhu XD; Liu L; Zhuang PY; Zhang JB; Zhang W; Xu HX; Kong LQ; Lu L; Wu WZ; Wang L; Tang ZY
Oncologist; 2010; 15(7):732-43. PubMed ID: 20551429
[TBL] [Abstract][Full Text] [Related]
85. Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice.
Ni Q; Ding K; Wang KQ; He J; Yin C; Shi J; Zhang X; Xie WF; Shi YQ
FEBS Lett; 2017 Jul; 591(13):1947-1957. PubMed ID: 28547778
[TBL] [Abstract][Full Text] [Related]
86. Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma.
Yuan RH; Lai HS; Hsu HC; Lai PL; Jeng YM
J Gastrointest Surg; 2014 Oct; 18(10):1784-94. PubMed ID: 25052070
[TBL] [Abstract][Full Text] [Related]
87. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
[TBL] [Abstract][Full Text] [Related]
88. p.Q511L mutation of HNF1α in hepatocellular carcinoma suppresses the transcriptional activity and the anti-tumor effect of HNF1α.
Ding CH; Deng LF; Chen F; Ding K; Chen WS; Xie WF; Zhang X
Biochem Biophys Res Commun; 2018 Jan; 495(1):86-91. PubMed ID: 29101032
[TBL] [Abstract][Full Text] [Related]
89. CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway.
Xue TC; Jia QA; Bu Y; Chen RX; Cui JF; Tang ZY; Ye SL
Oncol Rep; 2014 Dec; 32(6):2387-96. PubMed ID: 25242412
[TBL] [Abstract][Full Text] [Related]
90. Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Jeng KS; Sheen IS; Chen BF; Wu JY
Arch Surg; 2000 Nov; 135(11):1329-33. PubMed ID: 11074891
[TBL] [Abstract][Full Text] [Related]
91. Association between ephrin-A1 mRNA expression and poor prognosis after hepatectomy to treat hepatocellular carcinoma.
Wada H; Yamamoto H; Kim C; Uemura M; Akita H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Eguchi H; Umeshita K; Doki Y; Mori M; Nagano H
Int J Oncol; 2014 Sep; 45(3):1051-8. PubMed ID: 24969670
[TBL] [Abstract][Full Text] [Related]
92. A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells.
Chen L; Bao Y; Piekos SC; Zhu K; Zhang L; Zhong XB
Mol Pharmacol; 2018 Jul; 94(1):749-759. PubMed ID: 29691280
[TBL] [Abstract][Full Text] [Related]
93. Relationships between the expression of hepatocyte nuclear factors and factors essential for lipoprotein production in a human mesenchymal stem cell line, UE7T-13.
Sasaki A; Hiwatashi K; Kumagai M; Hata K; Kobayashi M
Biosci Biotechnol Biochem; 2017 Feb; 81(2):262-270. PubMed ID: 27838959
[TBL] [Abstract][Full Text] [Related]
94. Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.
Lien HC; Jeng YM; Jhuang YL; Yuan RH
PLoS One; 2018; 13(10):e0206261. PubMed ID: 30356299
[TBL] [Abstract][Full Text] [Related]
95. High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma.
Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
J Exp Clin Cancer Res; 2014 Apr; 33(1):32. PubMed ID: 24716838
[TBL] [Abstract][Full Text] [Related]
96. Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Yang Y; Quan ZW; Liu YB; Shen J
Oncotarget; 2014 Nov; 5(22):11121-32. PubMed ID: 25333267
[TBL] [Abstract][Full Text] [Related]
97. Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma.
Zhang JB; Guo K; Sun HC; Zhu XD; Zhang B; Lin ZH; Zhang BH; Liu YK; Ren ZG; Fan J
Br J Cancer; 2013 Sep; 109(6):1648-56. PubMed ID: 24002609
[TBL] [Abstract][Full Text] [Related]
98. Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.
Liao R; Wu H; Yi Y; Wang JX; Cai XY; He HW; Cheng YF; Zhou J; Fan J; Sun J; Qiu SJ
J Exp Clin Cancer Res; 2013 Apr; 32(1):22. PubMed ID: 23601182
[TBL] [Abstract][Full Text] [Related]
99. Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma.
Cai SH; Lu SX; Liu LL; Zhang CZ; Yun JP
Therap Adv Gastroenterol; 2017 Oct; 10(10):761-771. PubMed ID: 29051787
[TBL] [Abstract][Full Text] [Related]
100. Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection.
Désert R; Rohart F; Canal F; Sicard M; Desille M; Renaud S; Turlin B; Bellaud P; Perret C; Clément B; Lê Cao KA; Musso O
Hepatology; 2017 Nov; 66(5):1502-1518. PubMed ID: 28498607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
